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2Abstract
The human ear seems an unlikely candidate for therapies aimed at improving
cardiac function, but the ear and the heart share a common connection: the vagus
nerve. In recent years there has been increasing interest in the auricular branch of
the vagus nerve (ABVN), a unique cutaneous subdivision of the vagus distributed to
the external ear. Non-invasive electrical stimulation of this nerve through the skin
may offer a simple, cost-effective alternative to the established method of vagus
nerve stimulation (VNS), which requires a surgical procedure and has generated
mixed results in a number of clinical trials for heart failure. This review discusses the
available evidence in support of modulating cardiac activity using this strange
auricular nerve.
3The ear has been a site of therapeutic interest for millennia, including reports of
women in ancient Egypt using a heated needle to cauterise the skin of the ear as a
method of contraception (Gori et al., 2007). In ancient Greece, the physician
Hippocrates reported that blood-letting from veins on the posterior surface of the ear
could be used as a treatment for sexual dysfunction in men (Round et al., 2013).
Chinese traditional medicine, first developed over 3000 years ago, has also placed
an emphasis on using manual acupuncture of the ear or auricular acupuncture to
influence bodily functions through the concept of ‘Qi’ and meridians – energy
pathways associated with an intrinsic ‘life force’ which are believed to converge at
the level of the ear (He et al., 2012).
The ear is the site of a number of unusual reflexes including the pulmonoauricular
reflex, described in three tuberculosis patients with referred pain to the ear (Engel,
1979); the auriculogenital reflex in both male and female cats where mechanical or
electrical stimulation of the external ear elicited contraction of muscles around the
genitalia (Bradford, 1938); and the auriculouterine reflex, reported in a female patient
who felt severe pain in her left ear which coincided with menstruation (Engel, 1979).
An auriculocardiac reflex has been identified in a patient who experienced
bradycardia following stimulation of the posterior wall of the left external acoustic
meatus with a cotton-tipped ear probe (Thakar et al., 2008). Referred pain to the ear
as a result of angina and myocardial infarction has also been described, highlighting
the potential connectivity between the ear and the heart (Amirhaeri et al., 2010;
Rothwell, 1993).
The basis of these reflexes may be due to variation in the sensitivity of the auricular
branch of the vagus nerve (ABVN), which innervates the skin of parts of the ear and
the outer ear canal (external acoustic meatus). This branch of the vagus nerve is
4known as Arnold’s nerve after the German anatomist Friedrich Arnold (1803-1890),
who first observed that irritation of the posterior wall of the external acoustic meatus
elicited coughing in a small number of people (Arnold’s Reflex). Subsequent studies
have shown that such a response occurs in between 1.7%- 4.2% of individuals
(Bloustine et al., 1976; Gupta et al., 1986; Tekdemir et al., 1998) and arises due to
hypersensitivity of the ABVN (Ryan et al., 2014). This nerve is sometimes known too
as the Alderman’s nerve, a centuries-old reference to the Aldermen of the City of
London and their practice of using rosewater bowls at ceremonial banquets. The
banquet attendees were encouraged to place a table napkin moistened with
rosewater behind their ears with the belief that this promoted gastric emptying and
aided digestion (Treves, 1883).
Anatomy of the Auricular Branch of the Vagus Nerve
The ABVN is a remnant of the embryonic nerve supplying the first branchial arch
(Gupta et al., 1986) and is thought to be derived from nerves supplying the lateral
line organ in lower vertebrates such as fish, which use these cutaneous nerves to
sense vibrations and movement in the surrounding water (Engel, 1979; Hoagland,
1933). In mammals, the ABVN is distributed to the skin of the ear and external
acoustic meatus and consists of somatosensory afferent fibres, with their cell bodies
located in the jugular ganglion (DuBois et al., 1937). In humans, cadaveric
dissection has indicated that the ABVN is the only source of innervation to the cymba
concha and further innervates the antihelix, tragus and cavity of the concha (Peuker
et al., 2002). However, the skin of the ear receives additional sensory innervation
from trigeminal afferents (auriculotemporal nerve) and cervical spinal afferents (great
5auricular nerve and lesser occipital nerve; see figure 1), with a variable degree of
overlap in the respective dermatomes (Peuker et al., 2002).
How can stimulation of a small nerve in the ear elicit such a wide range of
physiological responses? The answer becomes clearer when the vagus nerve is
considered in its entirety. Regarded as the main parasympathetic output of the
autonomic nervous system, the vagus nerve has an extensive distribution throughout
the thorax and abdomen. In its role as the “great wandering protector” of the body, it
relays sensory information about the state of the body’s internal organs to the central
nervous system via afferent fibres which make up 80% of the nerve (Foley et al.,
1937). Upon exiting the cranium via the jugular foramen, the vagus provides
innervation to the soft palate, pharynx and muscles of the larynx prior to entering the
thorax (Berthoud et al., 2000). At this point, the ‘wandering’ nature of the vagus
becomes apparent through its complex distribution to the heart, lungs, liver, adrenal
medulla and the gastrointestinal tract up to the splenic flexure of the colon (Clancy et
al., 2013). The remaining 20% of vagus nerve fibres are efferent fibres originating
from the brainstem which provide parasympathetic control of the viscera and heart
(Foley et al., 1937).
The large number of afferent fibres in the vagus has led to it being investigated as a
therapeutic pathway for influencing brain activity by means of electrical stimulation.
In humans, vagus nerve stimulation (VNS) can be achieved by implanting an
electrical stimulator under the skin of the chest which stimulates the cervical vagus
nerve via a bipolar lead wrapped around the nerve. VNS was developed in the
1980s in patients with intractable epilepsy, is approved for the treatment of refractory
epilepsy and depression and has a well-established safety profile in these patients
(Groves et al., 2005; Morris et al., 1999; O'Reardon et al., 2006).
6Given the critical role of the vagus nerve in providing parasympathetic innervation to
the heart, there has been interest in using VNS to modulate cardiac function. In
animals, electrical stimulation of the cervical vagus nerve has been shown to evoke
cardiovascular effects, for example by lowering the ventricular fibrillation threshold
(Brack et al., 2013). Moreover, VNS is known to reduce incidence of ventricular
arrhythmias and mortality during ischemia (Brack et al., 2013) and prevent sudden
cardiac death in dogs with myocardial infarction (Vanoli et al., 1991). VNS has also
been investigated in animal models of chronic heart failure, a condition characterised
by a sustained increase in sympathetic drive and a concurrent withdrawal of
parasympathetic activity (Triposkiadis et al., 2009). A sustained improvement in
cardiac function and heart failure symptoms has been demonstrated as a result of
VNS (Hamann et al., 2013; Kusunose et al., 2014; Li et al., 2004; Sabbah et al.,
2011; Zhang et al., 2009).
The results of these animal studies combined with the well-established safety profile
of VNS has encouraged investigation into the feasibility and tolerability of VNS in
heart failure patients. Preliminary results using VNS showed promise and
stimulation of the right cervical vagus nerve with pulses synchronised to the cardiac
cycle improved NYHA class, quality of life scores and left ventricular end-systolic
volume (Schwartz et al., 2008). Larger studies subsequently showed VNS was
associated with a significant improvement in cardiac function, quality of life scores
and exercise performance (De Ferrari et al., 2011; Premchand et al., 2014).
However, a recent larger clinical trial concluded that 6 months of VNS failed to have
a significant effect on cardiac remodelling and cardiac function in heart failure
patients. Nevertheless, the study did show an improvement in quality of life
measures and NYHA classification (Zannad et al., 2015). A subsequent international
7multi-centre clinical trial using VNS on heart failure patients to assess whether VNS
increases the time to first event defined by all-cause mortality or unplanned heart
failure hospitalization was discontinued due to a statistical futility in this primary
efficacy endpoint (Gold et al., 2016). Although the safety profile of VNS is
recognised, the technique requires surgical implantation of the electrodes and a
subcutaneous battery pack, with an increased risk of post-operative complications
such as infection (Elliott et al., 2011). Other acute side-effects of VNS can include
neck pain, coughing, difficulty swallowing and voice alteration alongside nausea and
indigestion. In the longer term, hardware failure may necessitate revision surgery,
leaving patients at risk of experiencing a relapse in their symptoms until VNS can be
restored (Dlouhy et al., 2012). Since the ABVN of the ear can be electrically
stimulated through the skin without the need for an expensive surgical procedure,
targeting this site may provide an attractive therapeutic alternative with a greater
potential for widespread clinical use.
Cardiac effects of tVNS
Non-invasive or transcutaneous vagus nerve stimulation (tVNS) involves the use of
either electroacupuncture or specialised contact electrodes to pass a current through
the skin, with a high degree of heterogeneity in the literature in terms of stimulus
parameters and sites of application on the ear. In recent years the major sites of
interest for delivering electrical stimulation to the ABVN have been the inner surface
of the tragus (Busch et al., 2013; Clancy et al., 2014; Kraus et al., 2013; Stavrakis et
al., 2015; Weise et al., 2015; Zhou et al., 2016), the concha (Ay et al., 2015b; Fang
et al., 2015; He et al., 2013b; Liu et al., 2013), and the cymba concha (Frangos et
al., 2015; Kreuzer et al., 2014). In parallel with these ear studies, a method said to
8allow non-invasive cervical vagus nerve stimulation through the skin of the neck has
also been developed and is under investigation in patients with cluster headache
(Nesbitt et al., 2015) and migraine (Barbanti et al., 2015). Regardless of the exact
nature of the stimulation technique, the majority of the tVNS studies have followed
on from invasive VNS in their focus on neurological and psychiatric disorders, but
there has been increasing interest in whether or not tVNS could have beneficial
cardiac effects.
In anaesthetized dogs, chronic low-level stimulation of the tragus of the right ear
reversed atrial remodelling and inhibited the induction of atrial fibrillation elicited by 3
hours of prior rapid atrial pacing (Yu et al., 2013). Subsequent studies stimulating
the right or left tragus suppressed atrial fibrillation when performed alongside 9 hours
of atrial pacing by preventing the loss of the connexin proteins Cx40 and Cx43 in the
atrial tissue (Chen et al., 2015a; Chen et al., 2015b). When the same stimulation
protocol was applied to the left and right tragus of conscious dogs with healed
myocardial infarction, tVNS was improved cardiac function, alleviated cardiac fibrosis
and attenuated left ventricular remodelling (Wang et al., 2014; Wang et al., 2015).
This low-level tVNS reduced the plasma concentration of non-specific inflammatory
markers such as C-reactive protein and decreased the expression of various factors
which regulate cellular remodelling such as transforming growth factor beta 1 and
matrix metalloproteinase 9 (Wang et al., 2014; Wang et al., 2015). A decrease in the
concentration of plasma noradrenaline was further observed, suggesting that low-
level tVNS may decrease sympathetic nerve activity.
A number of human studies have also observed cardiac effects following tVNS.
Early pioneering studies in this area were performed on patients with coronary artery
disease and angina pectoris who were due to undergo surgery for coronary artery
9bypass grafting. Acupuncture needles with electrodes attached were placed into the
inferior concha of both ears and electrostimulation was applied for 15 minutes a day
for 10 days. This caused a reduction in the incidence of angina pectoris (a reduction
which lasted 2-3 weeks), improved the clinical course before and after surgery and
decreased the use of vasodilator treatment (Zamotrinsky et al., 1997; Zamotrinsky et
al., 2001). During surgery, atrial tissue was removed, and patients who had
undergone tVNS were found to have reduced levels of heat shock protein (HSP) 70i
and the ATP content of the tissue (Zamotrinsky et al., 1997). Following the surgery,
patients who had received tVNS had a significantly reduced incidence of acute heart
failure compared to patients who did not receive tVNS (Zamotrinsky et al., 2001). In
another study with coronary artery disease patients, Popov et al. (2013) stimulated
the auricular branch of the vagus by passing a low frequency electrical current
through electrodes on the internal surface of the auricle for 10 days. These
stimulation sessions caused nearly two-thirds of patients (62.5%) to report a
significant decrease in the intensity of angina attacks with an improvement in general
well-being (Popov et al., 2013). When the patient group was considered as a
complete cohort, tVNS did not alter any clinical results. However, when patients who
responded favourably to tVNS were studied as a separate group, their LF/HF ratio –
a non-invasive index of autonomic activity at the sinoatrial node - was significantly
lower following tVNS than before treatment, indicating a possible increase in vagus
nerve activity to the heart (Popov et al., 2013).
In patients with paroxysmal atrial fibrillation, 1 hour of low level tVNS under general
anaesthesia significantly decreased atrial fibrillation duration (induced by burst atrial
pacing), significantly increased atrial fibrillation cycle length and significantly
decreased systemic levels of the inflammatory factors tumour necrosis factor alpha
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(TNF-alpha) and C-reactive protein (Stavrakis et al., 2015). Meanwhile, in patients
with chronic heart failure and severe left ventricular dysfunction, a 15 day course of
daily tVNS sessions (increasing duration per session, up to 30 minutes) on the
internal surface of the auricle significantly increased distance of a 6 minute walk test
and improved the clinical condition in the majority of patients. In addition tVNS was
shown to have a bradycardiac effect in these patients along with increased levels of
heat shock proteins HSP60 and HSP70 in patients who had an initial heart rate of
less than 80 bpm. Patients with a heart rate greater than 80 bpm exhibited
increased the levels of HSP70 alone (Afanasiev et al., 2016). Cardiovascular
disorders therefore appear to be a suitable target for treatment with tVNS (see also
supplementary Table 1).
Mechanism of action of tVNS on cardiac function
The central projections of the ABVN have been investigated in the cat and rat.
Application of the transganglionic neuronal tracer horseradish peroxidase (HRP) to
the central cut end of the ABVN of the cat results in labelled fibres in the principal
sensory trigeminal nucleus, spinal trigeminal nucleus, nucleus tractus solitarius and
cuneate nucleus in the brainstem (Nomura et al., 1984). In rats, microinjection of
cholera toxin subunit B into the junction of the auricular concha and postero-inferior
wall of the external acoustic meatus produced labelled fibres in the lateral NTS and
the spinal trigeminal nucleus (He et al., 2013a).
In humans, fMRI scans have shown electrical stimulation of the left cymba concha
produces significant activation of “classical” central vagal projections including
widespread activity in the ipsilateral nucleus of the solitary tract (NTS), bilateral
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spinal trigeminal nucleus, dorsal raphe, locus coeruleus, contralateral parabrachial
area, amygdala and nucleus accumbens (Frangos et al., 2015). The connections of
the ABVN to the NTS may be of particular relevance to the cardiovascular effects
observed after tVNS. As mentioned, anatomical tracing studies in the cat (Nomura
et al., 1984) and rat (He et al., 2013a) have shown that the ABVN projects to the
NTS. Evidence that NTS neurones are activated following ABVN stimulation is
derived from studies in which electrical stimulation of the concha in rats with
transient focal ischemia elicits c-fos staining in the bilateral NTS and locus coeruleus
(Ay et al., 2015a).
In rats, a decrease in arterial pressure and heart rate can be elicited through
acupuncture-like stimulation of the inferior concha. Increased activity was observed
in NTS neurones with discharges synchronised to cardiac rhythm (Gao et al., 2011),
suggesting these neurones also received baroreceptor input. Some NTS neurones
receiving baroreceptor information are indeed known to project to the dorsal vagal
motor nucleus (DVN) and nucleus ambiguus (Deuchars et al., 2000), where
cardioinhibitory vagal efferent neurones are located (Izzo et al., 1993). The
observation by Yu et al (2013) that cardiovascular effects (reversal of atrial
remodelling and inhibition of atrial fibrillation elicited by atrial pacing) following
stimulation of the right tragus in anaesthetized dogs are eliminated by transection of
both vagus nerves indicates that vagal efferent fibres play a role in such
cardiovascular effects (Yu et al., 2013). It is therefore possible to propose that
auricular afferents can increase vagal efferent outputs by connections via the NTS
(see Figure 2).
In addition to vagal activation, a number of recent studies have shown that auricular
stimulation may also influence the activity of the sympathetic nervous system. In
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healthy human volunteers with no history of cardiovascular disease, tVNS on the
inner and outer surface of the tragus significantly improved heart rate variability
(through a shift in cardiac autonomic activity towards relative parasympathetic/vagal
dominance) and caused a significant decrease in muscle sympathetic nerve activity
as recorded by microneurography (Clancy et al., 2014). Further evidence that
electrical stimulation of the ABVN can elicit a decrease in sympathetic activity comes
from a study by Wang et al (2014), where a reduction in plasma noradrenaline
concentration was observed following bilateral tragus stimulation in conscious dogs
with healed myocardial infarction (Wang et al., 2014). Zhou et al (2016) also showed
that in anesthetized dogs, 3 hours of right tragus stimulation significantly attenuated
the sinus rate acceleration in response to right stellate ganglion stimulation and
decreased activity in the right stellate ganglion. In addition, tVNS has been found to
decrease expression of c-Fos, nerve growth factor and increase expression of SK2
at both the mRNA and protein level in the right stellate ganglion (Zhou et al., 2016).
The circuitry underlying this pathway is unknown, but may be via afferent excitation
of NTS neurones that send excitatory inputs to the caudal ventrolateral medulla
which in turn sends inhibitory inputs to the rostral ventrolateral medulla, the source of
excitatory drive to sympathetic efferents (Guyenet, 2006). Inhibition of the RVLM
therefore decreases sympathetic activity (see Figure 2).
tVNS, and not VNS?
Could the principal advantage of tVNS be its lack of a surgical procedure, or could
tVNS provide a more effective therapeutic alternative to VNS? The failure of the
VNS trials for the treatment of heart failure could be partly explained by recent
observations that the human cervical vagus nerve contains abundant tyrosine
13
hydroxylase-positive sympathetic nerve fibres distributed throughout the nerve
fascicles (Seki et al., 2014; Verlinden et al., 2016). Moreover, Verlinden and
colleagues found that the human right cervical vagus contains around twice as many
sympathetic fibres as the left cervical vagus (Verlinden et al., 2016). Similar
sympathetic structures have previously been observed in the canine cervical vagus
nerve, although the fibres were distributed to the periphery of the nerve (Onkka et
al., 2013). This apparent evolutionary vestige is in line with other species where
sympathetic and vagus fibres may be transmitted to the thorax via a common trunk
(Muryobayashi et al., 1968; Onkka et al., 2013). In addition, anatomical studies have
documented rich interactions between the right thoracic vagal nerve and the right
stellate ganglion at all levels(Ellison et al., 1969; Mizeres, 1955) and the rat superior
cervical ganglia have been found to contain bundles of nerve fibres derived from the
vagus nerve that are immunoreactive for calcitonin gene-related peptide and
substance P (Zaidi et al., 2013). Such anatomical studies suggest that stimulation of
the cervical vagus nerve may influence sympathetic activity through these interacting
nerve fibres. Indeed, when the cervical vagus was stimulated with intermittent
moderate stimulation in dogs, stellate ganglion neuron activity increased (Rhee et
al., 2015). This is likely an undesirable effect as enhanced sympathetic nerve activity
is associated with cardiovascular disease onset and progression (Triposkiadis et al.,
2009).
The question remains why, therefore, could tVNS be effective for treatment of
cardiovascular disease? A key consideration is that tVNS increases heart rate
variability and, critically, decreases muscle sympathetic nerve activity in healthy
humans (Clancy et al., 2014). Further, such cardiovascular diseases are associated
with increased inflammation and tVNS reduced plasma levels of non-specific
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inflammatory markers in conscious dogs with healed myocardial infarction (Wang et
al., 2014; Wang et al., 2015), as well as in patients with paroxysmal atrial fibrillation
(Stavrakis et al., 2015). Finally, the pathways through which tVNS functions are not
yet known (see Figure 2) – it is conceivable that they provide a more selective route
of action than those activated through cervical vagus stimulation. Further
investigations into such pathways and the effects of tVNS on the cardiovascular
system therefore seem warranted: the strange case of the ear and the heart remains
unsolved!
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Figures
Figure 1: Anatomical landmarks and cutaneous innervation of the external ear.
Three nerves contribute to the cutaneous innervation of the lateral aspect of the ear:
the auricular branch of the vagus nerve (ABVN), the auriculotemporal nerve (ATN)
and the great auricular nerve (GAN). There is a variable degree of overlap in the
distribution of these cutaneous nerves.
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Figure 2: Schematic of potential pathways though which stimulation of the auricular
branch of the vagus nerve (ABVN) could influence the heart. Stimulation of the
ABVN increases input to the nucleus of the solitary tract (NTS) in the medulla and
influences the activity of NTS neurones projecting to the cardioinhibitory vagal
efferent neurones of the DVN and NA. These vagal efferent neurones propagate the
vagal tone to the sinoatrial node (SA). Stimulation of the ABVN may also excite NTS
neurones sending excitatory projections to the caudal ventrolateral medulla (CVLM).
The CVLM inhibits the rostroventrolateral medulla (RVLM) which is the primary
source of excitatory drive to sympathetic preganglionic neurones in the
intermediolateral cell column (IML) of the spinal cord. This inhibition would decrease
sympathetic activity
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